Psychotropic drug prescribing in child and adolescent learning disability psychiatry

Journal of Psychopharmacology

Volumn 21, Issue 5, 2007, Pages 486-491

  Bramble, David ^a,b  

^a Services for Children and Young People   (United Kingdom)

^b Longbow House   (United Kingdom)

Author keywords

Autism; Mental retardation; Paediatric psychopharmacology; Prescribing

Indexed keywords

CARBAMAZEPINE; CLONIDINE; DEXAMPHETAMINE; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; MELATONIN; METHYLPHENIDATE; NEUROLEPTIC AGENT; PAROXETINE; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; RISPERIDONE; SERTRALINE; THIORIDAZINE; VALPROIC ACID;

ARTICLE; CHILD PSYCHIATRY; CONTROLLED STUDY; GENERAL PRACTITIONER; HUMAN; LEARNING DISORDER; MENTAL DEFICIENCY; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOPHARMACOLOGY; QUESTIONNAIRE; SCHOOL CHILD;

ADOLESCENT; ADOLESCENT PSYCHIATRY; ANTIPSYCHOTIC AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD PSYCHIATRY; DRUG THERAPY, COMBINATION; GREAT BRITAIN; HEALTH CARE SURVEYS; HUMANS; LEARNING DISORDERS; MENTAL RETARDATION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PSYCHOTROPIC DRUGS; QUALITY OF HEALTH CARE; QUESTIONNAIRES; WORKLOAD;

EID: 34547092685     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881106075642     Document Type: Article

References (18)

1. Aman M.G., Buican B., Arnold L.E. (2003) Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies. J Child Adolesc Psychopharmacology 13: 29 - 40
2. Aman M.G., Smedt G.D., Derivan A., Lyons B., Findling R.L. (2002) Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviours in children with subaverage intelligence. Am J Psychiatry 159: 1337 - 1346
3. American Association on Mental Retardation (2000) Expert Consensus Guidelines Series: treatment of psychiatric and behavioral problems in mental retardation. Am J Mental Retardation 105: 178 - 188
4. American Psychiatric Association (1994) Diagnostic and Statistical Manual for Mental Disorders, 4 th edn. American Psychiatric Association, Washington, DC
5. Bramble D. (1997) The use of psychostimulants by British child psychiatrists. Child Psychol Psychiatry Rev 2: 159 - 162
6. Bramble D. (1999) Stimulants and British learning disability psychiatrists. J Applied Res Intellectual Disabilities 12: 157 - 163
7. Bramble D., Feehan C. (2005) Psychiatrists' use of melatonin with children. Child Adolesc Mental Health 10: 145 - 149
8. British National Formulary 50 (2005) Section 4.3.3: Selective serotonin reuptake inhibitors. British Medical Association & Royal Pharmaceutical Society of Great Britain: 202 - 205
9. British National Formulary for Children (2005) Section 4.3.3: Selective serotonin re-uptake inhibitors. British Medical Association & Royal Pharmaceutical Society of Great Britain: 211 - 213
10. Cheng-Shannon J., McGough J.J., Pataki C., McCracken J.T. (2004) Second-generation antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacology 14: 372 - 394
11. Clarke A.F. (2004) Incidences of new prescribing by British child and adolescent psychiatrists: a prospective study over 12 months. J Psychopharmacology 18: 115 - 120
12. Committee on Safety of Medicines. (2003) Use of selective serotonin reuptake inhibitors (SSRIs) in children and adolescents with major depressive disorder (MDD). Available online at www.mca.gov/uk/aboutagency/regframework/csm/ csmhome.html
13. Department of Health (2004) Medicines Standard: National Service Framework for Children, Young People and Maternity Services. Department of Health Publications, ( http://www.dh.gov.uk/PolicyAndGuidance/ HealthAndSocialCareTopics/ChildrenServices/fs/en )
14. McBride P.A., Anderson G.M., Hertzig M.E. (1998) Effects of diagnosis, race and puberty on platelet serotonin levels in autism and mental retardation. J Am Acad Child Adolesc Psychiatry 37: 767 - 776
15. Murray M L., de Vries C S., Wonk I C K. (2004) A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database. Arch Dis Child 89: 1098 - 1102
16. Santosh P., Baird G. (1999) Psychopharmacotherapy in children and adults with learning disability. Lancet 354: 233 - 42
17. Silva R.R., Munoz D.M., Alpert A. (1996) Carbamazepine use in children and adolescents with features of attention deficit hyperactivity disorder: a meta-analysis. J Am Acad Child Adolesc Psychiatry 35: 352 - 358
18. Wong I C K, Murray M.L., Camilleri-Novak D., Stephens P. (2004) Increased prescribing trends of paediatric psychotropic medications. Arch Dis Child 89: 1131 - 1132